Search

everythinglearnresearchcommunity

for

Search:↓

A substance called VIP might protect hair follicles from being attacked by the immune system, and problems with VIP signaling could lead to hair loss in alopecia areata.

Dandruff might be caused by changes in how hair follicles naturally release oils and an immune response to this imbalance.

Cannabinoids may help treat various skin conditions.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

Alopecia areata is a hair loss condition caused by immune factors and can be treated with JAK inhibitors.

Light-based treatment, Photobiomodulation, shows promise for non-invasive skin therapy with few side effects.

Some cells may slow melanoma growth, a protein could affect skin pigmentation, a gene-silencing method might treat hair defects, skin bacteria changes likely result from eczema, and a defensin protein could help treat multiple sclerosis.

New findings suggest potential treatments for melanoma, hyperpigmentation, hair defects, and multiple sclerosis, and show skin microbiome changes don't cause atopic dermatitis.

Lichen Planopilaris and Frontal Fibrosing Alopecia may help us understand hair follicle stem cell disorders and suggest new treatments.

Human hair follicles have a scent receptor that can influence hair growth.

CGRP may help protect hair follicles from immune system attacks, potentially slowing hair loss.

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

Adipose mesenchymal stem cells are best for skincare because they reduce inflammation and are safe and effective.

Endocannabinoids help control mast cell activity in human skin.

Alopecia areata is caused by immune attacks on hair follicles, affecting hair growth and quality of life.

The document concludes that the immune-inhibitory environment of the hair follicle may prevent melanoma development.

A woman with alopecia regrew her hair after taking a higher dose of tocilizumab.

Activating STAT5 in the skin's dermal papilla is key for starting hair growth, regenerating hair follicles, and healing wounds.

The enzyme CD73 helps control human hair growth and could be targeted to treat hair growth disorders.

Blocking the CCR5 receptor may be a new way to treat hair loss from alopecia areata.

Restoring hair bulb immune privilege is crucial for managing alopecia areata.

Immune cells help regulate hair growth, and better understanding this can improve hair loss treatments.

Topical L-thyroxine may help with wound healing and hair growth but should be used short-term due to potential risks.

Hair follicles are hormone-sensitive and involved in growth and other functions, with potential for new treatments, but more research is needed.

Telogen is an active phase with important biological processes, not a resting phase.

Certain types of T cells are essential for healthy skin and play a role in skin diseases, but more research is needed to improve treatments.

Animal models have helped understand hair loss from alopecia areata and find new treatments.

Advanced nanocarrier and microneedle drug delivery methods are more effective, safer, and less invasive for treating skin diseases.

The document concludes that pregnancy and cancer share immune evasion tactics, but more research is needed before using checkpoint blockade immunotherapy in pregnant cancer patients to avoid harm to the placenta.

ILC1-like cells can cause alopecia areata by attacking hair follicles.